Natixis Prestige Consumer Healthcare Inc. Transaction History
Natixis
- $17.6 Billion
- Q3 2024
A detailed history of Natixis transactions in Prestige Consumer Healthcare Inc. stock. As of the latest transaction made, Natixis holds 247 shares of PBH stock, worth $20,449. This represents 0.0% of its overall portfolio holdings.
Number of Shares
247
Previous 247
-0.0%
Holding current value
$20,449
Previous $17,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding PBH
# of Institutions
335Shares Held
50.3MCall Options Held
6.3KPut Options Held
0-
Black Rock Inc. New York, NY8.28MShares$685 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.68MShares$470 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.96MShares$245 Million0.05% of portfolio
-
Ariel Investments, LLC Chicago, IL2.78MShares$230 Million2.25% of portfolio
-
Macquarie Group LTD Australia, C32.67MShares$221 Million0.21% of portfolio
About Prestige Consumer Healthcare Inc.
- Ticker PBH
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,762,600
- Market Cap $4.12B
- Description
- Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's an...